Articles by Daniel Marsh
BP Boardroom Turmoil Deepens as Ousted Chairman Fights Back
BP shares dropped 5.3% last week after chairman Albert Manifold was ousted, triggering reports of deeper boardroom clashes and raising questions about the company's turnaround.
Rolls-Royce Stock Rises for Fourth Day, Faces Key Resistance
Rolls-Royce shares extended gains for a fourth straight session, closing at 1,337.40p. The stock remains below its February high as traders watch upcoming dividend and aviation trends.
Asia Markets Mixed as AI Rally Boosts Japan and Taiwan, India Slips
Asian markets closed mixed on Friday, with Japan's Nikkei surging 2.53% on AI optimism, while India's Sensex fell 1.44% amid inflation concerns. Taiwan raised its 2026 GDP forecast to 9.64%.
Indian Equities End Week Sharply Lower; Nifty Below 23,550
Indian equities dropped sharply on Friday, with the Nifty 50 falling 1.5% and the Sensex losing over 1,000 points, as monsoon worries and foreign selling weighed on sentiment.
ASX 200 Surges 1.6% on US-Iran Truce Hopes
The ASX 200 surged 1.6% to 8,731.70 on Friday, its biggest daily gain in seven weeks, driven by hopes of a US-Iran ceasefire that could ease oil supply fears.
Plug Power Slips Again as Hydrogen Rally Faces Profitability Test
Plug Power shares fell 4.1% to $3.95 on Friday, as the hydrogen rally faces a critical test of profitability and cash management.
INVO Fertility Surges 14% Despite Filing Delays and Nasdaq Warning
INVO Fertility shares surged 14.1% to $1.88 on heavy volume, despite the company being late on financial filings and facing Nasdaq compliance issues.
Oculis Shares Plunge as Eye Drop Fails Key Trial Goal
Oculis shares tumbled 23.4% after two Phase 3 trials of OCS-01 eye drops for diabetic macular edema failed to meet the main vision goal. The company will not pursue U.S. approval for this indication.